Schedule 13D ownership disclosure

PYXIS ONCOLOGY INC

Common Stock, par value $0.001 per share · CUSIP: 747324101

Event date: 2024-12-23

Filing-level shares
6,624,699
Percent of class
10.3%
  • Lara SullivanReported CIK 0001769457

    Shares: 6,624,699 · Class: 10.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-24-139789
Form type
SCHEDULE 13D/A
Filer
Pyxis Oncology, Inc.
CIK
CIK 1782223
Filed
Dec 23, 2024
Reporting period
Dec 23, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub